Genomically, a characteristic of the IFNγ-signaturehigh basal/squamous subgroup is that the cancers carry elevated signatures of Apolipoprotein B mRNA Editing Catalytic Polypeptide-like (APOBEC) mediated mutagenesis [22]. This evidence concerns the gene IFNG and cancer.